The Women's Healthy Ageing Project: Fertile ground for investigation of healthy participants 'at risk' for dementia

International Review of Psychiatry

Volumn 25, Issue 6, 2013, Pages 726-737

  Szoeke, Cassandra E I ^a   Robertson, Joanne S ^a   Rowe, Christopher C ^a,b   Yates, Paul ^a,b   Campbell, Katherine ^a   Masters, Colin L ^a   Ames, David ^c   Dennerstein, Lorraine ^a,d   Desmond, Patricia ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^d Department of Psychiatry ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BIOLOGICAL MARKER;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; ATTENTION; AUSTRALIA; BRAIN ATROPHY; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEMENTIA; DEPTH PERCEPTION; EPIDEMIOLOGICAL DATA; EXECUTIVE FUNCTION; FEMALE; FEMALE FERTILITY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE; LIFESTYLE; LONGITUDINAL STUDY; MEMORY; MILD COGNITIVE IMPAIRMENT; MOOD; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; WOMEN'S HEALTH;

AGED; AGING; AUSTRALIA; DEMENTIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PRODROMAL SYMPTOMS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84892704057     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2013.873394     Document Type: Article

References (67)

1. Access Economics. (2004). Delaying the Onset of Alzheimer's Disease: Projections and Issues. Canberra: Alzheimer's Australia.
2. Access Economics. (2009). Keeping Dementia Front of Mind: Incidence and Prevalence 2009-2050. Canberra: Alzheimer's Australia.
3. AD International. (2010). World Alzheimer Report 2010: The Global Economic Impact of Dementia. London: Alzheimer's Disease International.
4. AD International. (2009). World Alzheimer Report (2009 ). London: Alzheimer's Disease International.
5. AIHW. (2012). Dementia in Australia. Canberra: Australian Institute of Health and Welfare.
6. Appannah, A., Szoeke, C., Ellis, K., Rowe, C., Martins, R., Masters, C., ... Bush, A. (2012a). The Commonwealth Scientific and Industrial Research Organisation report: Vascular risk and cognition-A combined cohort study.
7. Appannah, A., Szoeke, C., Ellis, K., Rowe, C., Martins, R., Masters, C., ... The AIBL Research Group. (2012b). Investigating cardiovascular risk factors on cognition: A two-cohort study. Alzheimer's and Dementia, 8 (4), S318-319.
8. Australian Bureau of Statistics. (1999). Disability, Ageing, and Carers: Summary of Findings, 1998. Retrieved from http://www.ausstats.abs.gov.au/ ausstats/subscriber.nsf-/0/CA25687100069 892CA25688800206521/$File/44300- 1998.pdf
9. Australian Bureau of Statistics. (2011) Australian Social Trends cat. no. 4102.0. Retrieved from http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/ LookupAttach/4102.0Publication23.03.112/$File/41020-Lifeexpectancy- Mar2011.pdf
10. Australian Government Department of Health and Ageing. (2013). Strategic Review of Health and Medical Research. Canberra: Australian Government Department of Health and Ageing.
11. Barry, L.C., Abou, J.J., Simen, A.A. & Gill, T.M. (2012). Under-treatment of depression in older persons. Journal of Affective Disorders, 136, 789-796.
12. Benke, T., Delazer, M., Sanin, G., Schmidt, H., Seiler, S., Ransmayr, G., ... Schmidt, R. (2013). Cognition, gender, and functional abilities in Alzheimer's disease: How are they related Journal of Alzheimer's Disease, 35, 247-252.
13. Bromberger, J.T., Kravitz, H.M., Chang, Y.F., Cyranowski, J.M., Brown, C. & Matthews, K.A. (2011). Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychological Medicine, 41, 1879-1888.
14. Campbell, K., Szoeke, C., Dennerstein, L. & Ames, D. (2012). Depression in the postmenopausal years: The second decade of follow-up in the Women's Healthy Ageing Project. Paper presented at the 16th Australasian Menopause Society Congress, Melbourne, Australia. Feb 12-Sun 14 October 2012.
15. Carrillo, M.C., Bain, L.J., Frisoni, G.B. & Weiner, M.W. (2012). Worldwide Alzheimer's disease neuroimaging initiative. Alzheimer's and Dementia, 8, 337-342.
16. Chen, K., Lowndes, G., Ames, D. & Szoeke, C. (2012). Variability in mid-life high-denisty lipoprotein cholesterol (HDL-C) is related to poorer late-life episodic memory: The Women's Healthy Ageing Project (WHAP). Alzheimer's and Dementia, 8 (4), S499.
17. Chételat, G., Villemagne, V.L., Bourgeat, P., Pike, K.E., Jones, G., Ames, D., ... Australian Imaging Biomarkers and Lifestyle Research Group. (2010). Relationship between atrophy and betaamyloid deposition in Alzheimer disease. Annals of Neurology, 67, 317-324.
18. DeCarli, C. (2013). Clinically asymptomatic vascular brain injury: A potent cause of cognitive impairment among older individuals. Journal of Alzheimer's Disease, 33, S417-S426.
19. Delis, D.C., Kaplan, E. & Kramer, J.H. (2001). The Delis-Kaplan Executive Function System (D-KEFS). San Antonio, TZ: Psychological Corporation.
20. Delis, D.C., Kramer, J.H., Kaplan, E. & Ober, B.A. (2000). California Verbal Learning Test - Second Edition. San Antonio, TX: Psychological Corporation.
21. Dennerstein, L., Dudley, E.C., Hopper, J.L., Guthrie, J.R. & Burger, H.G. (2000). A prospective population-based study of menopausal symptoms. Obstetrics and Gynecology, 96, 351-358.
22. Dennerstein, L., Smith, A.M.A. & Morse, C. (1994). Psychological well-being, mid-life, and the menopause. Maturitas, 20, 1-11.
23. Desmond, P., Cummins, T., Ames, D., Dennerstein, L. & Szoeke, C. (2013). The relationship between hassle severity, anxiety and cognitive performance: An 8 year follow-up in the Women's Health Ageing Project. Alzheimer's and Dementia, 9, 457.
24. Ellis, K., Szoeke, C., Bush, A., Darby, D., Graham, P.L., Lautenschlager, N.T., ... AIBL Research Group. (doi: 10.1017/s1041610213001956). Rates of diagnostic transition and cognitive change at 18 month follow up among 1112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). International Psychogeriatrics.
25. Ellis, K.A., Bush, A.I., Darby, D., De Fazio, D., Foster, J., Hudson, P., ... AIBL Research Group. (2009). The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672-687.
26. Gandy, S. & DeKosky, S.T. (2013). Toward the treatment and prevention of Alzheimer's disease: Rational strategies and recent progress. Annual Review of Medicine, 64, 367-383.
27. Gfeller, J.D. & Horn, G.J. (1996). The East Boston Memory Test: A clinical screening measure for memory impairment in the elderly. Journal of Clinical Psychology, 52 (2), 191-196.
28. Greendale, G.A., Huang, M.-H., Leung, K., Crawford, S.L., Gold, E.B., Wight, R., ... Karlamangla, A.S. (2012). Dietary phytoestrogen intakes and cognitive function during the menopausal transition: results from the Study of Women's Health Across the Nation Phytoestrogen Study. Menopause, 19, 894-903.
29. Greendale, G.A., Huang, M.-H., Wight, R.G., Seeman, T., Luetters, C., Avis, N.E., ... Karlamangla, A.S. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology, 72, 1850-1857.
30. Henderson, V.W., Guthrie, J.R., Dudley, E.C., Burger, H. G. & Dennerstein, L. (2003). Estrogen exposures and memory at midlife. Neurology, 60, 1369-1371.
31. Jack, C.R., Jr, Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., ... Trojanowski, J.Q. (2010). Personal View: Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet Neurology, 9, 119-128.
32. Jagust, W. J., Bandy, D., Chen, K., Foster, N. L., Landau, S. M., Mathis, C. A., ... The Alzheimer's Disease Neuroimaging Initiative. (2010). The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's and Dementia, 6, 221-229.
33. Judd, F., Hickey, M. & Bryant, C. (2012). Depression and midlife: Are we overpathologising the menopause Journal of Affective Disorders, 136, 199-211.
34. Lissner, L., Skoog, I., Andersson, K., Beckman, N., Sundh, V., Waern, M., ... Bj ö rkelund, C. (2003). Participation bias in longitudinal studies: Experience from the Population Study of Women in Gothenburg, Sweden. Scandinavian Journal of Primary Health Care, 21, 242-247.
35. Maki, P.M., Dennerstein, L., Clark, M., Guthrie, J., LaMontagne, P., Fornelli, D., ... Resnick, S.M. (2011). Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Research, 1379, 232-243.
36. Maki, P.M. & Sundermann, E. (2009). Hormone therapy and cognitive function. Human Reproduction Update, 15, 667-681.
37. Meyers, J.E. & Meters, K.R. (1995). Rey Complex Figure Test and Recognition Trial. Professional Manual: Psychological Assessment Resource, Inc.
38. Mohs, R.C., Knopman, D., Petersen, R.C., Ferris, S.H., Ernesto, C., Grundman, M.,... Thal, L.J. (1997). Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders, 11, S13-S21.
39. Morris, J.C., Roe, C.M., Xiong, C., Fagan, A.M., Goate, A.M., Holtzman, D.M. & Mintun, M.A. (2010). APOE predicts amyloid- beta but not tau Alzheimer pathology in cognitively normal aging. Annals of Neurology, 67 (1), 122-131.
40. Mullard, A. (2012). Sting of Alzheimer's failures offset by upcoming prevention trials. Nature Reviews Drug Discovery, 11, 657-660.
41. National Institutes of Health. (2010). NIH state-of-the-science conference statement on preventing Alzheimer's disease and cognitive decline. NIH Consensus and State-of-the-Science Statements, 27 (4), 1-27.
42. Nelson, H.E. & Willison, J.R. (1991). National Adult Reading Test (NART): Test manual (2nd ed.). Windsor: NFER-Nelson.
43. Pike, K., Ellis, K.A., Villemagne, V.L., Good, N., Chételat, G., Ames, D., ... Rowe, C.C. (2011). Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study. Neuropsychologia, 49, 2384-2390.
44. Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W. & Ferri, C.P. (2013). The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer's and Dementia, 9, 63-75.
45. Reed, B.R., Marchant, N.L., Jagust, W.J., DeCarli, C.C., Mack, W. & Chui, H.C. (2012). Coronary risk correlates with cerebral amyloid deposition. Neurobiology of Aging, 33, 1979-1987.
46. Rinne, J.O., Brooks, D.J., Rosser, M.N., Fox, N.C., Bullock, R., Klunk, W.E., ... Grundman, M. (2010). 11C-PiB PET assessment of change in fibrillar amyloid- βload in patients with Alzheimer's disease treated with bapineuzumab: A phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurology, 9, 363-372.
47. Rowe, C., Ackermann, U., Browne, W., Mulligan, R.S., Pike, K., O'Keefe, G., ... Villemagne, V. (2008). Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurology, 7, 129-135.
48. Rowe, C.C., Ellis, K.A., Rimajova, M., Bourgeat, P., Pike, K.E., Jones, G., ... Villemagne, V. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging, 31, 1275-1283.
49. Ryan, J., Stanczyk, F.Z., Dennerstein, L., Mack, W., Clark, M.S., Szoeke, C., ... Henderson, V.W. (2012). Hormone levels and cognitive function in postmenopausal midlife women. Neurobiology of Aging, 33, 1138-1147.
50. Salloway, S., Sperling, R., Gilman, S., Fox, N.C., Blennow, K., Raskind, M., ... Bapineuzumab 201 Clinical Trial Investigators. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology, 73, 2061-2070.
51. Saxton, J., Ratcliff, G., Munro, C.A., Coffey, C.E., Becker, J.T., Fried, L. & Kuller, L. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. The Clinical Neuropsychologist, 14 (4), 526-534.
52. Shepardson, N.E., Shankar, G.M. & Selkoe, D.J. (2011). Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Archives of Neurology, 68, 1385-1392.
53. Smith, A.M.A. (1982). Symbol Digits Modalities Test. Los Angeles: Western Psychological Services.
54. Strauss, E., Sherman, E.M.S. & Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (3rd ed.). New York: Oxford University Press.
55. Szoeke, C., Henderson, V.W., Ames, D. & Dennerstein, L. (2011). Reported memory complaints. Alzheimer's and Dementia, 7 (4), S365.
56. Vickland, V., Werner, J., Morris, T., McDonnell, G., Draper, B., Low, L.-F. & Brodaty, H. (2011). Who pays and who benefits How different models of shared responsibilities between formal and informal carers influence projections of costs of dementia management. BMC Public Health, 11, 793.
57. Villemagne, V.L., Burnham, S., Bourgeot, P., Brown, B., Ellis, K.A., Salvado, O., ... Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. (2013). Amyloid βdeposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurology, 12, 357-367.
58. Wechsler, D. (1997a). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio, TX: Psychological Corporation.
59. Wechsler, D. (1997b). Wechsler Memory Scale (3rd ed.). San Antonio, TX: Psychological Corporation.
60. Wechsler, D. (2001). Wechsler Test of Adult Reading: Examiner's Manual. San Antonio, TX: Psychological Corporation.
61. Welsh, K., Butters, N., Mohs, R., Beekly, D., Edland, S., Fillenbaum, G. & Heyman, A. (1994). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V: A normative study of the neuropsychological battery. Neurology, 44, 609-614.
62. WHO. (2011). Global Health and Ageing. NIH Publication no. 11-7737. Bethesda, MD: National Institute on Aging, National Institutes of Health and World Health Organization.
63. Wimo, A., Jönsson, L., Bond, J., Prince, M., Winblad, B. & Alzheimer Disease International. (2010). The worldwide economic impact of dementia. Alzheimer's and Dementia, 9, 1-11.
64. Wolf, P.A. (2012). Contributions of the Framingham Heart Study to stroke and dementa epidemiologic research at 60 years. Archives of Neurology, 69, 567-571.
65. Wortmann, M. (2011). Global economic cost of dementia. Alzheimer's and Dementia, 7 (4), S633.
66. Yang, L., Rieves, D. & Ganley, C. (2012). Brain amyloid imaging-FDA approval of Florbetapir F18. New England Journal of Medicine, 367, 885-887.
67. Yates, P., Szoeke, C., Rowe, C., Villemagne, V., Steward, C., Masters, C., ... Desmond, P. (2013). Ten-year MRI changes and FBB-PET: Results from the Women's Healthy Aging Project (WHAP). Alzheimer's and Dementia, 9 (4), S401.